Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Format: Podcast
A new law soon goes into effect that requires new or renewing DEA licensees, as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain. Dr Yngvild Olsen, director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration, joins AAAP to discuss the requirements going into effect, what should clinicians know about the changes, and how to best prepare.
Presenter(s):
Danae DiRocco, MD, MPH; Chun Tong, MD; and Yngvild K. Olsen, MD, MPH
Credit Available:
CE Credit(s): No
Certificate: No
Format: Webinar
The current opioid and drug overdose crisis continues to have a devastating impact on morbidity and mortality in the United States. With the rise in use of potent synthetic opioids like fentanyl in the drug supply, creating linkages to comprehensive substance use related services is critical. Opioid Treatment Programs (OTP) and the comprehensive care and services they provide play a vital role in addressing this need, yet challenges remain. Despite clear evidence of the benefits of OTP’s, access to OTPs in some parts of the country is limited; stigma related to the use of methadone remains a challenge. Yet in the face of these headwinds, many OTPs are providing comprehensive leading-edge services to address the opioid and drug overdose crisis.
Presenter(s):
Mark Parrino, President & CEO of The American Association for the Treatment of Opioid Dependence, Inc. and Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour
Format: Webinar
Opioid use disorder (OUD) can be a fatal addiction with complex implications for new and/or expecting mothers. OUD challenges can lead to many complications for mother and child, including low birth weight, clinical challenges with medical dosing and increased risk of accidental death. In the U.S. alone, a baby is born passively dependent every 15 minutes. To ensure best health outcomes for both mother and child, policies must allow engagement in evidence-based treatment and protect clients from legal ramifications. Hear from a physician, clinic director and an individual with lived experience to broaden understandings about the treatment and policy landscape for pregnant and postpartum women with OUD.
Presenter(s):
Maria Manriquez, M.D., FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour
Format: Clinical Tool
As deaths from opioid overdose and admissions to treatment facilities for opioid addiction increase , policymakers, researchers, and expert clinical societies agree that improved education on safe and appropriate opioid prescribing is a major priority.
Credit Available:
CE Credit(s): No
Certificate: No